Clinical Trial Update: The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

View source ↗

Summary

A Spain-based BALANCE trial is evaluating whether a patient support program improves outcomes for people with pulmonary fibrosis who are treated with nintedanib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• Nintedanib (Ofev) (Nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Fibrosis | Status: ACTIVE_NOT_RECRUITING